Sponsor Pipeline

Tianjin ConjuStar Biologics Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07080619 SC-101 in Subjects With Advanced NECTIN4-Amplified Cancers TNBC - Triple-Negative Breast Cancer Not Yet Recruiting
Phase 1
NCT06220838 Study SC-101 in Subjects With Advanced Malignancies Advanced Solid Tumor Recruiting
NCT06710158 Study of SC-102 in Patients With Advanced Solid Tumors Advanced Solid Cancers Recruiting
Disease Areas
Breast Cancer (1) Triple-Negative Breast Cancer (1)
Get alerts when Tianjin ConjuStar Biologics Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free